Research Progress of B-1 Cells in Periodontitis.

doi:10.13701/j.cnki.kqyxyj.2017.03.026

Abstract

Abstract: Periodontal local bacterial infection can cause inflammation of periodontal tissue, resulting in the destruction of periodontal tissue and tooth loss. In recent years, scholars found that a large proportion of B-1 cells accounted for periodontitis lesion infiltrating cells and conducted researches on the effect of B-1 cells in periodontitis. In this article, we performed a systematic review of B-1 cell in periodontitis in order to understand the research progress in this field and obtain the new ideas for the treatment of periodontitis.

Key words: Periodontitis , B-1 cell Autoimmunity, TypeⅠcollagen antibody, Natural antibody

CLC Number:

R780.1

WANG Yi-xiong, ZHANG Jin-cai. Research Progress of B-1 Cells in Periodontitis.[J]. Journal of Oral Science Research, 2017, 33(3): 339-341.

References

[1] And RB, Wortis HH. Origin and Functions of B-1 Cells with Notes on the Role of CD5 [J]. Annual Review of Immunology, 2002, 20(1)∶253-300
[2] Haas KM, Poe JC, Steeber DA, et al. B-1a and B-1b Cells Exhibit Distinct Developmental Requirements and Have Unique Functional Roles in Innate and Adaptive Immunity to S. pneumoniae [J]. Immunity, 2005, 23(1)∶7-18
[3] Hippen KL, Tze LE, Behrens TW. CD5 maintains tolerance in anergic B cells [J]. Journal of Experimental Medicine, 2000, 191(5)∶883-890
[4] Baumgarth N, Herman OC, Jager GC, et al. B-1 and B-2 Cell–Derived Immunoglobulin Mantibodies Are Non-redundant Components of the Protective Response to Influenza Virus Infection [J]. Journal of Experimental Medicine, 2000, 192(2)∶271-280
[5] Tumang JR, Rubén F, Seung Geun Y, et al. Spontaneously Ig-secreting B-1 cells violate the accepted paradigm for expression of differentiation-associated transcription factors [J]. Journal of Immunology, 2005, 174(6)∶3173-3177
[6] Hong Z, Casali P. Editorial: Epigenetics of B cells and antibody responses [J]. Frontiers in Immunology, 2015, 6
[7] Shaw PX, Horkko S, Chang M K, et al. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity [J]. Journal of Clinical Investigation, 2000, 105(12)∶1731-1740
[8] Ming Z, Austen W G, Isaac C, et al. Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury [J]. Proceedings of the National Academy of Sciences of the United States of America, 2004, 101(11)∶3886-3891
[9] Tumang J R, Hastings W D, Chunyan B, et al. Peritoneal and splenic B-1 cells are separable by phenotypic, functional, and transcriptomic characteristics [J]. European Journal of Immunology, 2004, 34(8)∶2158-67
[10] Murakami M, Tsubata T, Okamoto M, et al. Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice [J]. Nature, 1992, 357(6373)∶77-80
[11] Beebe AM, Cua DJ, Malefyt RD. The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS) [J]. Cytokine & Growth Factor Reviews, 2002, 13(4-5)∶403-412
[12] Zhinan Y, Gul B, Na Z, et al. IL-10 regulates murine lupus [J]. Journal of Immunology, 2002, 169(4)∶2148-2155
[13] Gunnarsson I, Nordmark B, Bakri AH, et al. Development of lupus-related side-effects in patients with early RA during sulphasalazine treatment-the role of IL-10 and HLA [J]. Rheumatology, 2000, 39(8)∶886-93
[14] Tyrrell-Price J, Lydyard P, Isenberg D. The effect of interleukin-10 and of interleukin-12 on the in vitro production of anti-double-stranded DNA antibodies from patients with systemic lupus erythematosus [J]. Clinical & Experimental Immunology, 2001, 124(1)∶118-125
[15] Ishikawa S, Sato T, Abe M, et al. Aberrant High Expression of B Lymphocyte Chemokine (BLC/Cxcl13) by C11b(+)Cd11c(+) Dendritic Cells in Murine Lupus and Preferential Chemotaxis of B1 Cells towards Blc [J]. Journal of Experimental Medicine, 2001, 193(12)∶1393-1402
[16] Taku S, Sho I, Kenji A, et al. Aberrant B1 cell migration into the thymus results in activation of CD4 T cells through its potent antigen-presenting activity in the development of murine lupus [J]. European Journal of Immunology, 2004, 34(12)∶3346-3358
[17] M. G. Newman, H. Takei, P. R. Klokkevold, and F. A. Carranza,Caranza,s Clinical Periodontology, Elsevier, 10th edition, 2006
[18] Tord B, Birgitta L, Jan L. Some cytokine profiles of T-helper cells in lesions of advanced periodontitis [J]. Journal of Clinical Periodontology, 2002, 29(8)∶705-709
[19] Berglundh T, Liljenberg B, Lindhe J. Some effects of periodontal therapy on local and systemic immunological parameters [J]. Journal of Clinical Periodontology, 1999, 26(2)∶91-98
[209] Donati M, Liljenberg B, Zitzmann N U, et al. B-1a cells and plasma cells in periodontitis lesions [J]. Journal of Periodontal Research, 2009, 44(5)∶683-688
[21] Sugawara M, Yamashita K, Yoshie H. &Hara K. Detection of, and anti-collagen antibody produced by, CD5-positive B cells in inflamed gingival tissues. Journal of Periodontal Research, 1992, 27∶489-498
[22] Aramaki M, Nagasawa T, Koseki T. & Ishikawa, I. Presence of activated B-1 cells in chronic inflamed gingival tissue [J]. Journal of Clinical Immunology, 1998, 18∶421-429
[23] Tord B, Birgitta L, Andrej T, et al. The presence of local and circulating autoreactive B cells in patients with advanced periodontitis[J]. Journal of Clinical Periodontology, 2002, 29(4)∶281-286
[24] Stein S H, Hart T E, Hoffman W H, et al. Interleukin-10 promotes anti-collagen antibody production in type I diabetic peripheral B lymphocytes [J]. Journal of Periodontal Research, 1997, 32(1)∶189-195
[25] Anusaksathien O, Dolby AE. Autoimmunity in periodontal disease [J]. Journal of Oral Pathology & Medicine, 1991, 20(3)∶101-107